Literature DB >> 34800258

Association of acidosis with coagulopathy and transfusion requirements in liver transplantation.

Júlia Ruete de Souza1, Ana Paula Yokoyama2,3, Mariana Munari Magnus4, Ilka Boin5, Elaine Cristina de Ataide5, Derli Conceição Munhoz6, Fabrício Bíscaro Pereira4, Angela Luzo4, Fernanda Andrade Orsi7.   

Abstract

The relationship between acidosis and coagulopathy has long been described in vitro and in trauma patients, but not yet in orthotopic liver transplantation (OLT). The association of metabolic acidosis with coagulopathy and with transfusion requirements was evaluated in patients submitted to OLT. Changes in acid-base and coagulation parameters were analyzed by repeated measures. Regression analyses [adjusted for sex, age, model for end stage liver disease (MELD) score, and baseline values of hemoglobin, fibrinogen, international normalized ratio, platelets] determined the association of acid-base parameters with coagulation markers and transfusion requirement. We included 95 patients, 66% were male, 49.5% of the patients had hepatocellular carcinoma and the mean MELD score was 20.4 (SD 8.9). The values of all the coagulation and acid-base parameters significantly changed during OLT, particularly in the reperfusion phase. After adjustments for baseline parameters, the decrease in pH and base excess (BE) values were associated with a decrease in fibrinogen levels (mean decrease of fibrinogen level = 14.88 mg/dL per 0.1 unit reduction of pH values and 3.6 mg/dL per 1 mmol/L reduction of BE levels) and an increase in red blood cells transfusion (2.16 units of RBC per 0.1 unit reduction of pH and 0.38 units of RBC per 1 mmol/L reduction of BE levels). Among multiple factors potentially associated with adverse outcomes, decreasing pH levels were independently associated with the length of hospitalization but not with in-hospital mortality. Metabolic acidosis is independently associated with decreased fibrinogen levels and increased intraoperative transfusion requirement during OLT. Awareness of that association may improve treatment strategies to reduce intraoperative bleeding risk in OLT.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Acidosis; Coagulation; Orthotopic liver transplantation; Risk factor; Transfusion

Mesh:

Substances:

Year:  2021        PMID: 34800258     DOI: 10.1007/s11239-021-02609-x

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN: 0929-5305            Impact factor:   2.300


  29 in total

1.  Blood transfusion requirement during liver transplantation is an important risk factor for mortality.

Authors:  Abbas Rana; Henrik Petrowsky; Johnny C Hong; Vatche G Agopian; Fady M Kaldas; Douglas Farmer; Hasan Yersiz; Jonathan R Hiatt; Ronald W Busuttil
Journal:  J Am Coll Surg       Date:  2013-03-09       Impact factor: 6.113

2.  Physical chemical approach versus traditional technique in analyzing blood gases and electrolytes during liver transplant surgery.

Authors:  Y Ali; S Abouelnaga; H Khalaf; Y Kamel
Journal:  Transplant Proc       Date:  2010-04       Impact factor: 1.066

3.  Evaluation for liver transplantation in adults: 2013 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation.

Authors:  Paul Martin; Andrea DiMartini; Sandy Feng; Robert Brown; Michael Fallon
Journal:  Hepatology       Date:  2014-03       Impact factor: 17.425

4.  Rifle criteria for acute kidney dysfunction following liver transplantation: incidence and risk factors.

Authors:  A Kundakci; A Pirat; O Komurcu; A Torgay; H Karakayalı; G Arslan; M Haberal
Journal:  Transplant Proc       Date:  2010-12       Impact factor: 1.066

Review 5.  Acid-base disorders in liver disease.

Authors:  Bernhard Scheiner; Gregor Lindner; Thomas Reiberger; Bruno Schneeweiss; Michael Trauner; Christian Zauner; Georg-Christian Funk
Journal:  J Hepatol       Date:  2017-07-03       Impact factor: 25.083

6.  Intraoperative massive transfusion decreases survival after liver transplantation.

Authors:  I F S F Boin; M I Leonardi; A C M Luzo; A R Cardoso; C A Caruy; L S Leonardi
Journal:  Transplant Proc       Date:  2008-04       Impact factor: 1.066

Review 7.  Coagulopathy management in liver transplantation.

Authors:  A Sabate; A Dalmau; M Koo; I Aparicio; M Costa; L Contreras
Journal:  Transplant Proc       Date:  2012 Jul-Aug       Impact factor: 1.066

Review 8.  Transfusion and coagulation management in liver transplantation.

Authors:  Ben Clevenger; Susan V Mallett
Journal:  World J Gastroenterol       Date:  2014-05-28       Impact factor: 5.742

9.  Fencl-Stewart analysis of acid-base changes immediately after liver transplantation.

Authors:  David A Story; Rakesh Vaja; Stephanie J Poustie; Larry McNicol
Journal:  Crit Care Resusc       Date:  2008-03       Impact factor: 2.159

10.  Persistent acidosis after reperfusion-A prognostic indicator of increased 30-day and in-hospital postoperative mortality in liver transplant recipients.

Authors:  Sang Kim; Samuel DeMaria; Jiawen Li; Hung-Mo Lin; Natalie Smith; David Wax; Bryan Hill; Ashley So; Parissa Tabrizian; Sander Florman; Dennis Feierman; Jeron Zerillo
Journal:  Clin Transplant       Date:  2019-01-24       Impact factor: 2.863

View more
  1 in total

1.  Advancing Prediction of Risk of Intraoperative Massive Blood Transfusion in Liver Transplantation With Machine Learning Models. A Multicenter Retrospective Study.

Authors:  Sai Chen; Le-Ping Liu; Yong-Jun Wang; Xiong-Hui Zhou; Hang Dong; Zi-Wei Chen; Jiang Wu; Rong Gui; Qin-Yu Zhao
Journal:  Front Neuroinform       Date:  2022-05-13       Impact factor: 3.739

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.